My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 200

    1.

    Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes.

    Korytkowski M, Thomas A, Reid L, Tedesco MB, Gooding WE, Gerich J.

    Diabetes Care. 2002 Sep;25(9):1607-11.PMID: 12196435 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.

    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.

    Diabet Med. 1997 Jul;14(7):556-63.PMID: 9223393 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.

    Tan M, Johns D, González Gálvez G, Antúnez O, Fabián G, Flores-Lozano F, Zúñiga Guajardo S, Garza E, Morales H, Konkoy C, Herz M; GLAD Study Group.

    Clin Ther. 2004 May;26(5):680-93.PMID: 15220012 [PubMed - indexed for MEDLINE]Related articles

    4.

    Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study.

    Rizzo MR, Barbieri M, Grella R, Passariello N, Barone M, Paolisso G.

    Diabetes Metab. 2004 Feb;30(1):81-9.PMID: 15029102 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.

    Clark HE, Matthews DR.

    Horm Metab Res. 1996 Sep;28(9):445-50.PMID: 8911981 [PubMed - indexed for MEDLINE]Related articles

    6.

    Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes.

    Juhl CB, Pørksen N, Pincus SM, Hansen AP, Veldhuis JD, Schmitz O.

    Diabetes. 2001 Aug;50(8):1778-84.PMID: 11473038 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group.

    Riddle MC, Schneider J.

    Diabetes Care. 1998 Jul;21(7):1052-7.PMID: 9653594 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

    Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC.

    Diabetes Care. 1998 May;21(5):810-6.PMID: 9589246 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 diabetes mellitus.

    Kabadi MU, Kabadi UM.

    Clin Ther. 2004 Jan;26(1):63-9.PMID: 14996518 [PubMed - indexed for MEDLINE]Related articles

    10.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    11.

    Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.

    Sonnenberg GE, Garg DC, Weidler DJ, Dixon RM, Jaber LA, Bowen AJ, DeChemey GS, Mullican WS, Stonesifer LD.

    Ann Pharmacother. 1997 Jun;31(6):671-6.PMID: 9184703 [PubMed - indexed for MEDLINE]Related articles

    12.

    Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes.

    Overkamp D, Volk A, Maerker E, Heide PE, Wahl HG, Rett K, Häring HU.

    Diabetes Care. 2002 Nov;25(11):2065-73.PMID: 12401758 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of acarbose on insulin sensitivity in elderly patients with diabetes.

    Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D.

    Diabetes Care. 2000 Aug;23(8):1162-7.PMID: 10937515 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.

    Cusi K, Cukier S, DeFronzo RA, Torres M, Puchulu FM, Redondo JC.

    J Clin Endocrinol Metab. 2001 Mar;86(3):1410-7.PMID: 11238540 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.

    Ravikumar B, Gerrard J, Dalla Man C, Firbank MJ, Lane A, English PT, Cobelli C, Taylor R.

    Diabetes. 2008 Sep;57(9):2288-95. Epub 2008 Jun 5.PMID: 18535187 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.

    Ligtenberg JJ, Reitsma WD, van Haeften TW.

    Horm Metab Res. 2001 Jun;33(6):361-4.PMID: 11456286 [PubMed - indexed for MEDLINE]Related articles

    17.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

    Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.

    Diabetes Care. 2006 Nov;29(11):2371-7.PMID: 17065670 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.

    Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.

    J Clin Endocrinol Metab. 1990 Jun;70(6):1594-602.PMID: 2189885 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.

    van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW.

    Diabetes Care. 1998 Feb;21(2):278-82.PMID: 9539996 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity